| A dual‐responsive antibiotic‐loaded nanoparticle specifically binds pathogens and overcomes antimicrobial‐resistant infections M Ye, Y Zhao, Y Wang, M Zhao, N Yodsanit, R Xie, D Andes, S Gong Advanced Materials 33 (9), 2006772, 2021 | 128 | 2021 |
| Biomimetic fibrin-targeted and H2O2-responsive nanocarriers for thrombus therapy Y Zhao, R Xie, N Yodsanit, M Ye, Y Wang, S Gong Nano Today 35, 100986, 2020 | 92 | 2020 |
| pH‐responsive polymer–drug conjugate: an effective strategy to combat the antimicrobial resistance M Ye, Y Zhao, Y Wang, N Yodsanit, R Xie, S Gong Advanced Functional Materials 30 (39), 2002655, 2020 | 85 | 2020 |
| A pH-responsive silica–metal–organic framework hybrid nanoparticle for the delivery of hydrophilic drugs, nucleic acids, and CRISPR-Cas9 genome-editing machineries Y Wang, PK Shahi, R Xie, H Zhang, AA Abdeen, N Yodsanit, Z Ma, ... Journal of Controlled Release 324, 194-203, 2020 | 83 | 2020 |
| Hydrogen peroxide-responsive platelet membrane-coated nanoparticles for thrombus therapy Y Zhao, R Xie, N Yodsanit, M Ye, Y Wang, B Wang, LW Guo, KC Kent, ... Biomaterials science 9 (7), 2696-2708, 2021 | 46 | 2021 |
| Recent progress on nanoparticles for targeted aneurysm treatment and imaging N Yodsanit, B Wang, Y Zhao, LW Guo, KC Kent, S Gong Biomaterials 265, 120406, 2021 | 26 | 2021 |
| Biomimetic, ROS-detonable nanoclusters—A multimodal nanoplatform for anti-restenotic therapy Y Zhao, T Shirasu, N Yodsanit, E Kent, M Ye, Y Wang, R Xie, AC Gregg, ... Journal of Controlled Release 338, 295-306, 2021 | 22 | 2021 |
| Multimodal nanoimmunotherapy engages neutrophils to eliminate Staphylococcus aureus infections J Zhu, R Xie, R Gao, Y Zhao, N Yodsanit, M Zhu, JC Burger, M Ye, Y Tong, ... Nature Nanotechnology, 1-12, 2024 | 18 | 2024 |
| An adventitial painting modality of local drug delivery to abate intimal hyperplasia T Shirasu, N Yodsanit, X Xie, Y Zhao, Y Wang, R Xie, Y Huang, B Wang, ... Biomaterials 275, 120968, 2021 | 14 | 2021 |
| Evaluation of ethyl N-(2-phenethyl) carbamate analogues as biofilm inhibitors of methicillin resistant Staphylococcus aureus MD Stephens, N Yodsanit, C Melander Organic & biomolecular chemistry 14 (28), 6853-6856, 2016 | 14 | 2016 |
| Targeted PERK inhibition with biomimetic nanoclusters confers preventative and interventional benefits to elastase-induced abdominal aortic aneurysms N Yodsanit, T Shirasu, Y Huang, L Yin, ZH Islam, AC Gregg, AM Riccio, ... Bioactive materials 26, 52-63, 2023 | 13 | 2023 |
| Injectable hydrogel capable of in situ covalent crosslinking for permanent embolization R Xie, YC Chen, Y Zhao, N Yodsanit, Y Wang, N Yamamoto, ... ACS Applied Materials & Interfaces 13 (48), 56988-56999, 2021 | 13 | 2021 |
| Double-network nanogel as a nonviral vector for DNA delivery M Ye, Y Wang, Y Zhao, R Xie, N Yodsanit, K Johnston, S Gong ACS applied materials & interfaces 11 (46), 42865-42872, 2019 | 12 | 2019 |
| Neointima abating and endothelium preserving—An adventitia-localized nanoformulation to inhibit the epigenetic writer DOT1L T Shirasu, N Yodsanit, J Li, Y Huang, X Xie, R Tang, Q Wang, M Zhang, ... Biomaterials 301, 122245, 2023 | 5 | 2023 |
| Potentiation of the fosmidomycin analogue FR 900098 with substituted 2-oxazolines against Francisella novicida MD Stephens, N Yodsanit, C Melander MedChemComm 7 (10), 1952-1956, 2016 | 3 | 2016 |
| Tissue adhesive unimolecular micelles directly painted onto the adventitia for decreasing intimal hyperplasia T Shirasu, N Yodsanit, X Xie, B Wang, S Gong, L Guo, KC Kent Journal of Vascular Surgery 75 (4), 13S, 2022 | 2 | 2022 |
| Innovative Hybrid Nanocarriers of GnRH Peptide‐Modified Chitosan‐Coated Lipid Nanoparticles as a Targeted Chemotherapy for Reproductive‐Related Cancers P Bunwatcharaphansakun, N Yodsanit, W Keaswejjareansuk, P Gonil, ... Journal of Biomedical Materials Research Part A 113 (2), e37843, 2025 | | 2025 |
| Nano-based perivascular intervention sustains a nine-month long-term suppression of intimal hyperplasia in vein grafts T Shirasu, G Urabe, N Yodsanit, Y Huang, R Xie, MS Stratton, M Joseph, ... Bioactive Materials 44, 82-96, 2025 | | 2025 |
| An adventitial painting modality of local drug delivery to abate intimal hyperplasia KC Kent, LW Guo, T Shirasu, B Wang, G Shaoqin, N Yodsanit US Patent App. 18/562,898, 2024 | | 2024 |
| Nano-Based Perivascular Intervention Sustains a Nine-Month Long-Term Suppression of Intimal Hyperplasia in Vein Grafts Y Huang, T Shirasu, G Urabe, N Yodsanit, M Stratton, M Joseph, R Xie, ... JVS-Vascular Science 5, 2024 | | 2024 |